Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing
The 39-year-old vegetarian woman with vitamin B12 deficiency (pernicious anaemia) who was taking monthly injections of 10mg cyanocobalamin, referred to allergy clinic, and commonly presented with itchy, exanthematous skin rashes about 30min after the tenth dose
Specific numbers from animal studies include: reported upregulation of growth hormone receptor expression in tendon fibroblasts, effects on VEGF-mediated tube formation in endothelial cell assays, and dose-dependent reductions in gastric ulcer area in rat models at doses ranging from 10 micrograms per kilogram to higher concentrations
Not sure where from but I think from VersandApo thru Amazon
